Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy

Topic: Brain proteins, microglia and lab models

Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB) are clinically and neuropathologically highly related α-synucleinopathies that collectively constitute the second leading cause of neurodegenerative dementias. Genetic and neuropathological studies directly implicate α-synuclein (αS) abnormalities in PDD and DLB pathogenesis. However, it is currently unknown how αS abnormalities contribute to memory loss, particularly since forebrain neuronal loss in PDD and DLB is less severe than in Alzheimer's disease. Previously, we found that familial Parkinson's disease-linked human mutant A53T αS causes aberrant localization of the microtubule-associated protein tau to postsynaptic spines in neurons, leading to postsynaptic deficits. Thus, we directly tested if the synaptic and memory deficits in a mouse model of α-synucleinopathy (TgA53T) are mediated by tau. TgA53T mice exhibit progressive memory deficits associated with postsynaptic deficits in the absence of obvious neuropathological and neurodegenerative changes in the hippocampus. Significantly, removal of endogenous mouse tau expression in TgA53T mice (TgA53T/mTau -/- ), achieved by mating TgA53T mice to mouse tau-knockout mice, completely ameliorates cognitive dysfunction and concurrent synaptic deficits without affecting αS expression or accumulation of selected toxic αS oligomers. Among the known tau-dependent effects, memory deficits in TgA53T mice were associated with hippocampal circuit remodeling linked to chronic network hyperexcitability. This remodeling was absent in TgA53T/mTau -/- mice, indicating that postsynaptic deficits, aberrant network hyperactivity, and memory deficits are mechanistically linked. Our results directly implicate tau as a mediator of specific human mutant A53T αS-mediated abnormalities related to deficits in hippocampal neurotransmission and suggest a mechanism for memory impairment that occurs as a consequence of synaptic dysfunction rather than synaptic or neuronal loss. We hypothesize that these initial synaptic deficits contribute to network hyperexcitability which, in turn, exacerbate cognitive dysfunction. Our results indicate that these synaptic changes present potential therapeutic targets for amelioration of memory deficits in α-synucleinopathies.

Key findings

• Previously, we found that familial Parkinson's disease-linked human mutant A53T αS causes aberrant localization of the microtubule-associated protein tau to postsynaptic spines in neurons, leading to postsynaptic deficits.
• TgA53T mice exhibit progressive memory deficits associated with postsynaptic deficits in the absence of obvious neuropathological and neurodegenerative changes in the hippocampus.
• Significantly, removal of endogenous mouse tau expression in TgA53T mice (TgA53T/mTau -/- ), achieved by mating TgA53T mice to mouse tau-knockout mice, completely ameliorates cognitive dysfunction and concurrent synaptic deficits without affecting αS expression or accumulation of selected toxic αS oligomers.
• Among the known tau-dependent effects, memory deficits in TgA53T mice were associated with hippocampal circuit remodeling linked to chronic network hyperexcitability.
• Our results directly implicate tau as a mediator of specific human mutant A53T αS-mediated abnormalities related to deficits in hippocampal neurotransmission and suggest a mechanism for memory impairment that occurs as a consequence of synaptic dysfunction rather than synaptic or neuronal loss.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1007/s00401-019-02032-w
• PubMed: 31168644
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{singh2019-31168644,
  author  = {Singh, B. and Covelo, A. and Martell-Martínez, H. and Nanclares, C. and Sherman, M. A. and Okematti, E. and Meints, J. and Teravskis, P. J. and others},
  title   = {{Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy}},
  journal = {Acta neuropathologica},
  year    = {2019},
  doi     = {10.1007/s00401-019-02032-w},
  pmid    = {31168644},
  url     = {https://doi.org/10.1007/s00401-019-02032-w}
}

Related studies in Disease mechanisms

• Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits American Journal Of Pathology · 2006-08-01 · usefulness score 40/100
• 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013-09-11 · usefulness score 36/100
• Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model Journal of neurotrauma · 2005-10-01 · usefulness score 38/100
• Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease Hippocampus · 2010-11-10 · usefulness score 36/100
• (−)‐Epicatechin Rescues Memory Deficits by Activation of Autophagy in a Mouse Model of Tauopathies MedComm · 2025-03-24 · usefulness score 34/100
• A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024-05-23 · usefulness score 46/100

Similar studies

• Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau 2002 · Disease mechanisms
• Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease 2011 · Disease mechanisms
• Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration 2005 · Disease mechanisms
• Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function 2005 · Disease mechanisms
• Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein 2006 · Disease mechanisms
• In vivo tau pathology is associated with synaptic loss and altered synaptic function 2021 · Disease mechanisms

More on Disease mechanisms

• A review that covers this ground Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer's Disease Molecular neurobiology · 2016-10-13 · usefulness score 39/100
• Newest in this subject Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation bioRxiv · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Disease mechanisms →